The Anxiolytic-Like Effects of the Novel, Orally Active Nociceptin Opioid Receptor Agonist 8-[bis(2-Methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510)Geoffrey B. Varty, Galen Carey, Julius J. Matasi et al.|Journal of Pharmacology and Experimental Therapeutics|2008Cited by 83
Nociceptin inhibits capsaicin-induced bronchoconstriction in isolated guinea pig lungMichel R. Corboz, John A. Hey, Maria A. Rivelli et al.|European Journal of Pharmacology|2000Cited by 56
2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs as adenosine A2A antagonists: The successful reduction of hERG activity. Part 2Julius J. Matasi, Deen Tulshian, John P. Caldwell et al.|Bioorganic & Medicinal Chemistry Letters|2005Cited by 21
Synthesis and structure–activity relationships of N-substituted spiropiperidines as nociceptin receptor ligandsJohn P. Caldwell, Deen Tulshian, Julius J. Matasi et al.|Bioorganic & Medicinal Chemistry Letters|2007Cited by 19
2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs: Highly potent, orally active, adenosine A2A antagonists. Part 1Julius J. Matasi, Deen Tulshian, Hongtao Zhang et al.|Bioorganic & Medicinal Chemistry Letters|2005Cited by 17